Improved pharmacovigilance to monitor and promote the safety of the WHO recommendation is needed.
World Health Organization
IPTp-AZCQ was not superior to IPTp-SP in this study and alternatives for IPTp-SP remain to be identified.
In these countries, stock-outs were the most important single obstacle to the smooth operations of continuous LLIN distribution.
MIR-PLS was found to be suitable for the quality control of these drugs.
The Malaria Policy Advisory Committee (MPAC) to the World Health Organization held its eighth meeting in Geneva, Switzerland from 16 to 18 September 2015.
This study is one of the few to demonstrate significant improvement in clinical outcomes and process measures following the introduction of RDTs for the diagnosis of malaria at a rural health facility in Uganda.
To achieve biological conservation and to eliminate Plasmodium parasites in human populations, the World Health Organization Malaria Eradication Research Agenda should take biodiversity issues into consideration.
Safety, immunogenicity and efficacy of the RTS,S/AS02D vaccine candidate when integrated into a standard EPI schedule for infants have been reported over a nine-month surveillance period. This paper describes results following 20 months of follow up.
This new journal reminds us of the essential characteristic of poverty as a violent abuse of human rights. The context of poverty ? its social, political and economic dimensions ? remain in the reader?s mind as evidence is provided on technical solutions to managing the infectious diseases that afflict poor populations world-wide
The primary outcome is the proportion of patients attending facilities that report a fever or suspected malaria and receive treatment according to malaria guidelines.